Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Sofodelevier vs Sovaldi in Healthy Volunteers
NCT03062423Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Oct 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sofosbuvir in hepatitis C (HCV) (3 arms), sponsored by Genuine Research Center. Primary endpoints: Maximal measured plasma concentration, Area under the plasma concentration-time curve from time zero to time t and 1 more. Started Oct 2016; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03062423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03062423.